Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of nanobacteria in urologic disease.

Literature DB >> 16402263

The role of nanobacteria in urologic disease.

Abstract

Recent data proposing an extremely small, self-replicating agent termed "nanobacteria" has raised a great deal of controversy within the scientific community. Since these agents have been isolated within the genitourinary tract, much research has focused attention on the potential role these particles may play in the development of urologic pathology, including polycystic kidney disease, renal calculi, and chronic prostatitis. Recent clinical research targeting these agents has proven effective in treating some patients with refractory category III prostatitis (chronic pelvic pain syndrome). This article reviews the current state of nanobacteria research and explore where these particles may impact urologic disease.

Entities: Disease Species

Mesh：

Year: 2006 PMID： 16402263 DOI： 10.1007/s00345-005-0041-3

Source DB: PubMed Journal: World J Urol ISSN： 0724-4983 Impact factor: 4.226

22 in total

1. Living nanovesicles--chemical and physical survival strategies of primordial biosystems.

Authors: Andrei P Sommer; David S McKay; Neva Ciftcioglu; Uri Oron; Adam R Mester; E Olavi Kajander
Journal: J Proteome Res Date: 2003 Jul-Aug Impact factor: 4.466

2. Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis.

Authors: Yu Wen; Yong-guo Li; Zhu-lin Yang; Xue-jun Wang; Hong Wei; Wei Liu; Xiong-ying Miao; Qun-wei Wang; Sheng-fu Huang; Jing Yang; E Olavi Kajander; Neva Ciftcioglu
Journal: Chin Med J (Engl) Date: 2005-03-05 Impact factor: 2.628

3. Nanobacteria: an infectious cause for kidney stone formation.

Authors: N Ciftçioglu; M Björklund; K Kuorikoski; K Bergström; E O Kajander
Journal: Kidney Int Date: 1999-11 Impact factor: 10.612

4. [Calcifications of the prostate: a transrectal echographic study].

Authors: E Bock; V Calugi; V Stolfi; P Rossi; R D'Ascenzo; F M Solivetti
Journal: Radiol Med Date: 1989-05 Impact factor: 3.469

5. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization.

Authors: G Hudelist; C F Singer; E Kubista; M Manavi; R Mueller; K Pischinger; K Czerwenka
Journal: Histopathology Date: 2004-12 Impact factor: 5.087

6. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience.

Authors: Daniel A Shoskes; Kim D Thomas; Eyda Gomez
Journal: J Urol Date: 2005-02 Impact factor: 7.450

7. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves.

Authors: Virginia M Miller; George Rodgers; Jon A Charlesworth; Brenda Kirkland; Sandra R Severson; Todd E Rasmussen; Marineh Yagubyan; Jeri C Rodgers; Franklin R Cockerill; Robert L Folk; Ewa Rzewuska-Lech; Vivek Kumar; Gerard Farell-Baril; John C Lieske
Journal: Am J Physiol Heart Circ Physiol Date: 2004-05-13 Impact factor: 4.733

8. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy.

Authors: Benedict S. Maniscalco; Karen A. Taylor
Journal: Pathophysiology Date: 2004-10

9. Peripheral neuropathy and light-preliminary report indicating prevalence of nanobacteria in HIV.

Authors: Andrei P Sommer
Journal: J Proteome Res Date: 2003 Nov-Dec Impact factor: 4.466

10. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure.

Authors: Tomislav M Jelic; Amer M Malas; Samuel S Groves; Bo Jin; Paul F Mellen; Garry Osborne; Rod Roque; James G Rosencrance; Ho-Huang Chang
Journal: South Med J Date: 2004-02 Impact factor: 0.954

10 in total

1. Management of urinary tract infections associated with nephrolithiasis.

Authors: Patricia D Brown
Journal: Curr Infect Dis Rep Date: 2010-11 Impact factor: 3.725

Review 2. Autosomal dominant polycystic kidney disease and transplantation.

Authors: Mariusz Niemczyk; Stanisław Niemczyk; Leszek Paczek
Journal: Ann Transplant Date: 2009 Oct-Dec Impact factor: 1.530

3. Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment.

Authors: Qing-hua Zhang; Xue-cheng Shen; Zhan-song Zhou; Zhi-wen Chen; Gen-sheng Lu; Bo Song
Journal: Int Urogynecol J Date: 2009-09-17 Impact factor: 2.894

4. Evaluation of chronic pelvic pain syndrome in men: is it chronic prostatitis?

Authors: Raymond M Bernal; Michel A Pontari
Journal: Curr Urol Rep Date: 2009-07 Impact factor: 3.092

Review 5. Etiology of chronic prostatitis/chronic pelvic pain syndrome: psychoimmunoneurendocrine dysfunction (PINE syndrome) or just a really bad infection?

Authors: Michel A Pontari
Journal: World J Urol Date: 2013-04-12 Impact factor: 4.226

6. Tetracycline attenuates calcifying nanoparticles-induced renal epithelial injury through suppression of inflammation, oxidative stress, and apoptosis in rat models.

Authors: Yuqing Zhang; Rujian Zhu; Dong Liu; Min Gong; Wei Hu; Qingtong Yi; Jie Zhang
Journal: Transl Androl Urol Date: 2019-12

7. Detection of nanobacteria in patients with chronic prostatitis and vaginitis by reverse transcriptase polymerase chain reaction.

Authors: Tae-Hyoung Kim; Hye Ryoun Kim; Soon-Chul Myung
Journal: Korean J Urol Date: 2011-03-18